At Amneal, helping people get the medicine they need has always been important to us. We understand that during this time, you may have questions and concerns about your insurance coverage. And we want to assure you that case managers from the MyRYTARY Patient Support Program are standing by to help you understand the implications of any coverage changes you may experience due to COVID-19. They can also connect you with programs that may make your medication more affordable. Even if you're not currently enrolled in the MyRYTARY Patient Support Program, you can speak to a case manager by calling 1-844-467-2928 Monday through Friday, 8:00 AM to 8:00 PM ET. To learn more about the support services this program offers, visit MyRYTARY.com.
We've also been carefully monitoring our supply chain to ensure that RYTARY will continue to be safely manufactured and available in pharmacies, and we do not foresee any issues arising as a result of this pandemic.
While the world navigates COVID-19, the members of the Parkinson's community remain our priority.
PP-RYT-US-0105 04/2020
You will now be directed to a Parkinson's treatment website